Carole S. Ben-Maimon
2014 - Impax Laboratories
In 2014, Carole S. Ben-Maimon earned a total compensation of $3.4M as Former President, Impax Generics Division at Impax Laboratories, a 92% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $453,248 |
|---|---|
| Option Awards | $584,100 |
| Salary | $458,022 |
| Stock Awards | $580,520 |
| Other | $1,351,249 |
| Total | $3,427,139 |
Ben-Maimon received $1.4M in other compensation, accounting for 39% of the total pay in 2014.
Ben-Maimon also received $453.2K in non-equity incentive plan, $584.1K in option awards, $458K in salary and $580.5K in stock awards.
Rankings
In 2014, Carole S. Ben-Maimon's compensation ranked 2,558th out of 13,032 executives tracked by ExecPay. In other words, Ben-Maimon earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,558 out of 13,032 | 80th |
Division Manufacturing | 907 out of 4,966 | 82nd |
Major group Chemicals And Allied Products | 280 out of 1,686 | 83rd |
Industry group Drugs | 217 out of 1,365 | 84th |
Industry Pharmaceutical Preparations | 179 out of 1,043 | 83rd |
Source: SEC filing on April 14, 2015.
Ben-Maimon's colleagues
We found six more compensation records of executives who worked with Carole S. Ben-Maimon at Impax Laboratories in 2014.
2014
G Wilkinson
Impax Laboratories
Chief Executive Officer
2014
Larry Hsu
Impax Laboratories
Chief Executive Officer
2014
Michael Nestor
Impax Laboratories
President, Impax Specialty Pharma division
2014
Mark Schlossberg
Impax Laboratories
General Counsel
2014
Bryan Reasons
Impax Laboratories
Chief Financial Officer
2014
Jeffrey Nornhold
Impax Laboratories